Member Info for Uncanny

You are funny Laura.

Laura this expired almost a year ago now!

https://www.globenewswire.com/en/news-release/2023/10/05/2755433/0/en/EUDA-Health-Holdings-Limited-Enters-into-Letter-of-Intent-for-Proposed-Merger-with-TheoremRx-Inc.html

“…..signed a letter of intent dated October 4, 2023, with respect to the proposed merger with TheoremRx Inc. (“TheoremRx”), a private U.S.-based company focused on the development of new treatments with safe administration, low toxicity, and a high potential for polypharmacy usage to benefit patients suffering from cancer and women’s health conditions.

The two parties have agreed to a 30-day exclusivity period, which may be extended by an additional 15 days by mutual agreement“

FYI

https://tinyurl.com/4zfefp77

Page 8

LOL Laura, l am here and grounded but please DYOR as you can see, the money EUDA is too raise (it hasn’t even happened yet!) is for general working capital purposes unfortunately.

Read it again:

“USE OF PROCEEDS

Except as described in any prospectus supplement and any free writing prospectus in connection with a specific offering, we plan to use the net proceeds for general corporate purposes, which may include working capital, capital expenditures, research and development expenditures and the acquisitions of new technologies and investments.”

No THX mention and no merger mention.

Just to mention if you read the EUDA prospectus there is absolutely no mention of THX or a merger, so l think you can kiss 201 news soon goodbye IMHO:

“USE OF PROCEEDS

Except as described in any prospectus supplement and any free writing prospectus in connection with a specific offering, we plan to use the net proceeds for general corporate purposes, which may include working capital, capital expenditures, research and development expenditures and the acquisitions of new technologies and investments . When a particular series of securities is offered, the prospectus supplement relating to that offering will set forth our intended use of the net proceeds received from the sale of those securities.”

No mention whatsoever sadly.

Profitjock - yes!

Yes, l agree updates to arrive but a lot here from all the under £1000 sized buys gambling on it being positive which it might not be. That’s all l am saying and certainly no mention of the word “deal” l heard!

Anything price sensitive would have to be done via official RNS of course, not in a webinar.

PM, l really hope so but l didn’t read it like that.

I just heard two updates coming which could be the opposite my friend.

PM, you say:

“201 news first if you watched the presentation so back to sleep Porky.”

Please remember the news might not be what you want up hear!

Calmness required

Well done ME, good guy and honest presentation but I am not getting too carried away as yet as the 401 news could be a no from Ambrose, plus news on 201 might also be a no TBH and might say that they have broken with THX and looking for new avenues so I am trying to stay grounded.

Sadly PM, the cake is burnt and the icing on the top (CLX) is great but it won’t be ready in time so we’re going to have to go back to the supermarket and buy a new cake but we’ll need to go to the bank first to get an overdraft (placing) as there’s no money left (cash at bank) to buy another with. I did think of using the old cake ingredients in the cupboard (legacy assets) but sadly they have expired and they won’t work.

That’s the cake scenario to me.

Takeover, LOL.

Thank you Laura.

Had a read through the EUDA prospectus and firstly no mention of THX whatsoever and also no timescale so a lot of BS rose tinted finger crossing below to try and ramp things up by two posters with +10 post to their name which sadly smells a bit fishy LOL, so l think VAL will still do a fund raise regardless as running on fumes so dilution will be inevitable IMHO, albeit a good effort by our two new posting friends LOL

Why would 201 need to be reformulated as it had a 54.5% response rate just 3 years ago? Of course it needs further trials which is why a partner was required by VAL to take it forward as it would cost minimum of c. $20 million.

EUDA is a red herring IMHO as they haven’t even got any funds yet, it’s just a prospectus and VAL need cash now!

Webinar IMHO is to set out ME’s strategy and drop a fund raise perhaps to coincide with an RNS on the same day?

We will see!

One thing that keeps popping up time and time again is whether 201 is still a commercial IP or is it now dated - question for ME….. l think it was end of 2020 when the last clinical update RNS was released.

Some good points raised there, thanks guys.

Firstly - these should be questions in the Q & A and not just be mooted on a BB, to whoever is in attendance at the Webinar!

THX - we know already that ME has given them an ultimatum on timescale, but I think the exclusivity needs to be removed like in China to allow other parties to get in and get this signed off once and for all.

LAB - not too bothered about what has been paid thus far, but more what the estimated cash-in flows will be for the next 12-24 months

CLX - my only question being our No.1 asset would be 'when' can this be ready to sell? Now or does it need more work and if so how long? Plus, generally is there any interest in CLX, 201 now?

401 - I think IMHO what has been said below is a bit of a wild theory and I believe they have taken 401 in good faith to evaluate.

Is this the troop rally before a fund raise?

Northern hero

Thanks for your posts, so am l right in thinking that you believe 401 with Ambrose and 201 with THX are highly unlikely to progress at all now?

You are blinkered Laura, yes the lP is great, the cash position is not l feel.